Hot flash severity in hormone therapy users/nonusers across the menopausal transition

Maturitas

Volumn 58, Issue 2, 2007, Pages 191-200

  Smith DiJulio, Kathleen ^a   Percival, Donald B ^a   Woods, Nancy Fugate ^a   Tao, Eunice Y ^a   Mitchell, Ellen Sullivan ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Hormone replacement therapy; Hot flash severity; Menopausal transition; Menopause; Postmenopause

Indexed keywords

ESTRONE; FOLLITROPIN; GLUCURONIDE;

ADULT; AGING; ALCOHOL CONSUMPTION; ANXIETY; ARTICLE; BODY MASS; CLIMACTERIUM; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HORMONAL THERAPY; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; MENOPAUSE; POSTMENOPAUSE; PSYCHOSOCIAL CARE; QUESTIONNAIRE; REPRODUCTION; SCORING SYSTEM; SLEEP; STRESS; URINALYSIS;

ADULT; ESTROGEN REPLACEMENT THERAPY; ESTRONE; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; HOT FLASHES; HUMANS; MENOPAUSE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; WASHINGTON; WOMEN'S HEALTH;

EID: 34848906221     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2007.08.003     Document Type: Article

References (51)

1. Guthrie J.R., Dennerstein L., Taffe J.R., and Donnelly V. Health care-seeking for menopausal problems. Climacteric 6 (2003) 112-117
2. Zapantis G., and Santoro N. Ovarian ageing and the menopausal transition. Best Pract Res Clin Obstet Gynaecol 16 (2002) 263-276
3. Santoro N., Brown J.R., Adel T., and Skurnick J. Characterizaton of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab 81 (1996) 1495-1501
4. Santoro N. The menopause transition: an update. Hum Reprod Update 8 (2002) 155-160
5. Randolph Jr. J.F., Sowers M., Gold E.B., et al. Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab 88 (2003) 1516-1522
6. Rannevik G., Jeppsson S., Johnell O., Bjerre B., Laurell-Borulf Y., and Svanberg L. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 21 (1995) 103-113
7. Burger H.G., Dudley E.C., Robertson D.M., and Dennerstein L. Hormonal changes in the menopause transition. Recent Prog Horm Res 57 (2002) 257-275
8. Holte A. Influences of natural menopause on health complaints: a prospective study of healthy Norwegian women. Maturitas 14 (1992) 127-141
9. Freeman E.W., Grisso J.A., Berlin J., Sammel M., Garcia-Espana B., and Hollander L. Symptom reports from a cohort of African American and white women in the late reproductive years. Menopause 8 (2001) 33-42
10. Dennerstein L., Dudley E.C., Hopper J.L., Guthrie J.R., and Burger H.G. A prospective population-based study of menopausal symptoms. Obstet Gynecol 96 (2000) 351-358
11. Gold E.B., Colvin A., Avis N., et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation. Am J Public Health 96 (2006) 1226-1235
12. Matthews K.A., Wing R.R., Kuller L.H., et al. Influences of natural menopause on psychological characteristics and symptoms of middle-aged healthy women. J Consult Clin Psychol 58 (1990) 345-351
13. Binfa L., Castelo-Branco C., Blumel J.E., et al. Influence of psycho-social factors on climacteric symptoms. Maturitas 48 (2004) 425-431
14. Freeman E.W., Sammel M.D., Lin H., Gracia C.R., Kapoor S., and Ferdousi T. The role of anxiety and hormonal changes in menopausal hot flashes. Menopause 12 (2005) 258-266
15. Juang K.D., Wang S.J., Lu S.R., Lee S.J., and Fuh J.L. Hot flashes are associated with psychological symptoms of anxiety and depression in peri- and post- but not premenopausal women. Maturitas 52 (2005) 119-126
16. Avis N.E., Crawford S.L., and McKinlay S.M. Psychosocial, behavioral, and health factors related to menopause symptomatology. Womens Health 3 (1997) 103-120
17. Hahn P.M., Wong J., and Reid R.L. Menopausal-like hot flashes reported in women of reproductive age. Fertil Steril 70 (1998) 913-918
18. Gold E.B., Block G., Crawford S., et al. Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the Study of Women's Health Across the Nation. Am J Epidemiol 159 (2004) 1189-1199
19. Guthrie J.R., Dennerstein L., Taffe J.R., Lehert P., and Burger H.G. Hot flushes during the menopause transition: a longitudinal study in Australian-born women. Menopause 12 (2005) 460-467
20. North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 11 (2004) 11-33
21. Kuh D.L., Wadsworth M., and Hardy R. Women's health in midlife: the influence of the menopause, social factors and health in earlier life. Br J Obstet Gynaecol 104 (1997) 923-933
22. Li S., and Holm K. Physical activity alone and in combination with hormone replacement therapy on vasomotor symptoms in postmenopausal women. West J Nurs Res 25 (2003) 274-288 [discussion 289-93]
23. Randolph Jr. J.F., Sowers M., Bondarenko I., et al. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition. J Clin Endocrinol Metab 90 (2005) 6106-6112
24. Overlie I., Moen M.H., Holte A., and Finset A. Androgens and estrogens in relation to hot flushes during the menopausal transition. Maturitas 41 (2002) 69-77
25. Woods N.F., Smith-DiJulio K., Percival D.B., Tao E.Y., Taylor H.J., and Mitchell E.S. Symptoms during the menopausal transition and early postmenopause and their relation to endocrine levels over time: observations from the Seattle Midlife Women's Health Study. J Womens Health 16 (2007) 667-677
26. Thurston R.C., Blumenthal J.A., Babyak M.A., and Sherwood A. Emotional antecedents of hot flashes during daily life. Psychosom Med 67 (2005) 137-146
27. Gallicchio L., Visvanathan K., Miller S.R., et al. Body mass, estrogen levels, and hot flashes in midlife women. Am J Obstet Gynecol 193 (2005) 1353-1360
28. Ivarsson T., Spetz A.C., and Hammar M. Physical exercise and vasomotor symptoms in postmenopausal women. Maturitas 29 (1998) 139-146
29. Lindh-Astrand L., Nedstrand E., Wyon Y., and Hammar M. Vasomotor symptoms and quality of life in previously sedentary postmenopausal women randomised to physical activity or estrogen therapy. Maturitas 48 (2004) 97-105
30. Thurston R.C., Joffe H., Soares C.N., and Harlow B.L. Physical activity and risk of vasomotor symptoms in women with and without a history of depression: results from the Harvard Study of Moods and Cycles. Menopause 13 (2006) 553-560
31. Schilling C., Gallicchio L., Miller S.R., et al. Current alcohol use is associated with a reduced risk of hot flashes in midlife women. Alcohol Alcohol 40 (2005) 563-568
32. Mitchell E.S., Woods N.F., and Mariella A. Three stages of the menopausal transition from the Seattle Midlife Women's Health Study: toward a more precise definition. Menopause 7 (2000) 334-349
33. Soules M.R., Sherman S., Parrott E., et al. Executive summary: stages of reproductive aging workshop (STRAW). Climacteric 4 (2001) 267-272
34. Chiazze Jr. L., Brayer F.T., Macisco Jr. J.J., Parker M.P., and Duffy B.J. The length and variability of the human menstrual cycle. JAMA 203 (1968) 377-380
35. World Health Organization. Research on menopause in the 1990s. Report No. 866. Geneva; 1996.
36. Norbeck J.S. Modification of life event questionnaires for use with female respondents. Res Nurs Health 7 (1984) 61-71
37. Derogatis L.R., Rickels K., and Rock A.F. The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Br J Psychiatry 128 (1976) 280-289
38. Woods N.F., Carr M.C., Tao E.Y., Taylor H.J., and Mitchell E.S. Increased urinary cortisol levels during the menopause transition. Menopause 13 (2006) 212-221
39. Pinheiro J.C., and Bates D.M. Mixed-effects models in S and S-PLUS (2000), Springer, New York
40. Pinheiro J, Bates D, DebRoy S, Sarkar D. nlme: linear and nonlinear mixed effects models. In. 3.1-66 ed: R package; 2005.
41. R Core Development Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2005.
42. Hox J. Multilevel analysis: techniques and applications (2002), Lawrence Elrbaum Associates, Mahwah, NJ
43. Ferrell R.J., O'Connor K.A., Rodriguez G., et al. Monitoring reproductive aging in a 5-year prospective study: aggregate and individual changes in steroid hormones and menstrual cycle lengths with age. Menopause 12 (2005) 567-577
44. Gill S., Lavoie H.B., Bo-Abbas Y., and Hall J.E. Negative feedback effects of gonadal steroids are preserved with aging in postmenopausal women. J Clin Endocrinol Metab 87 (2002) 2297-2302
45. Limpaphayom K., Taechakraichana N., and Kittinunvorakoon C. Serum estradiol and gonadotropins level in postmenopausal women with or without hormone replacement. J Med Assoc Thai 80 (1997) 147-152
46. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
47. Hall P., Ploner A., Bjohle J., et al. Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study. BMC Med 4 (2006) 16
48. Loi S., Haibe-Kains B., Desmedt C., et al. Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. J Clin Oncol 25 (2007) 1239-1246
49. Freedman R.R., and Subramanian M. Effects of symptomatic status and the menstrual cycle on hot flash-related thermoregulatory parameters. Menopause 12 (2005) 156-159
50. Freedman R.R. Pathophysiology and treatment of menopausal hot flashes. Semin Reprod Med 23 (2005) 117-125
51. Freedman R.R. Hot flashes: behavioral treatments, mechanisms, and relation to sleep. Am J Med 118 Suppl 12B (2005) 124-130